Additionally, our findings follow previous results showing that NPS-1034 plays a crucial regulatory role as an inhibitor in both the MET and AXL pathways in solid tumors, such as lung cancer [23,34] and gastric cancer [30]. This evidence concerns the gene AXL and lung carcinoma.